The Indian company received permission to test a potential vaccine against the coronavirus in humans
As reported by The Times of Indiais India’s first vaccine approved for this stage of testing.
Clinical studies of the drug COVAXIN on humans can begin after the company will provide the results of preclinical safety tests and the formation of the immune response. It is expected that tests on volunteers will begin in July.